The SUPPORT for Patients and Communities Reauthorization Act of 2025 reauthorizes and expands federal funding for substance use disorder and mental health programs through FY2030. This directly increases demand for related healthcare services, diagnostics, and pharmaceutical distribution, creating a sustained revenue stream for companies operating in these areas.
TICKER INTELLIGENCE
$COO
Company & Legislative Profile
$COO is a publicly traded company in the Healthcare sector. This company operates across Healthcare and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 1 active Congressional signal mentioning $COO, including 1 bill. The current legislative sentiment is predominantly bullish, suggesting potential tailwinds from government policy.
$COO is currently facing 1 active congressional signal tracked by HillSignal. With 1 bullish, and 0 bearish signal, the average legislative impact score is 8.0/10. Key sectors affected include Healthcare. Recent major catalysts include SUPPORT for Patients and Communities Reauthorization Act of 2025. Below is the complete tracker of government activity affecting $COO’s market performance.
1
Total Signals
8.0/10
Avg Impact
1
Bullish Signals
0
Bearish Signals
Related Sectors
Recent Congressional Signals for $COO
Understanding These Signals
Get Full Access to $COO Signals
Daily AI-analyzed alerts for Congressional activity affecting your portfolio.
Become a Member →